Loading clinical trials...
Loading clinical trials...
Objective of this study is to increase knowledge about safety, tolerability, quality of life and efficacy under conditions of routine use of sunitinib.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Pfizer
NCT06852638 · Renal Cancer, Renal Clear Cell Carcinoma, and more
NCT07540260 · Radiation Therapy, Metastatic Renal Cancer, and more
NCT05969496 · Renal Cancer, Kidney Cancer, and more
NCT07123090 · Metastatic Renal Cell Carcinoma, Metastatic Renal Cancer, and more
NCT00026884 · Malignant Neoplasms, Hereditary Neoplastic Syndromes, and more
Pfizer Investigational Site
Banská Bystrica
Pfizer Investigational Site
Bojnice
Pfizer Investigational Site
Bratislava
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions